Poor metabolisers of nicotine and CYP2D6 polymorphism
- 1 January 1994
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 343 (8888) , 62-63
- https://doi.org/10.1016/s0140-6736(94)90921-0
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- The role of individual human cytochrpmes P450 in drug metabolism and clinical responseTrends in Pharmacological Sciences, 1992
- Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypesPharmacogenetics, 1991
- Titrating exposure to tobacco smoke using cotinine—a minefield of misunderstandingsJournal of Clinical Epidemiology, 1990
- Gas chromatographic determination of trans-3′-hydroxycotinine, a major metabolite of nicotine in smokersJournal of Chromatography B: Biomedical Sciences and Applications, 1987